Zelmic AB is a Contract Research Organisation (CRO) in Lund – Sweden, founded in 2002 and has vast expertise in the development of pharmaceutical formulations for topical drugs.

Zelmic’s have a strong track record of bringing topical products from idea to clinical testing. Zelmic has inhouse formulation, GMP analytical chemistry, and in vitro release capability to bring value to the drug development companies and can handle small molecules, peptides, and proteins. Moreover, Zelmic’s team members have been working with drug delivery technologies and have put both oral, parental, and dermatological products on the market.